According to the latest edition of the World Intellectual Property Organisation’s Global Innovation Index (GII), Japan is home to the world’s largest science and technology cluster.
Cancer is currently the leading cause of death in Japan, as it has been for the past forty years, and demand for novel oncology is now at an all-time high. Whereas Japan used to suffer a ‘drug lag,’ targeted government subsidies and private sector collaboration means
